NXT Capital announced that it has provided a $40 million senior credit facility to fund Swander Pace Capital’s acquisition of Captek Softgel International, Inc. NXT Capital was the lead arranger, administrative agent and sole bookrunner for this transaction. 

Swander Pace Capital is a leading private equity firm specializing in investments in growth-oriented, middle-market consumer companies in North America and the United Kingdom. With cumulative equity commitments of approximately $1.3 billion, for the past 19 years Swander Pace Capital has used its expertise in this industry to pursue a consistent strategy of acquiring or investing in consumer products companies with leading market positions in attractive, defensible niches. Swander Pace Capital has led successful private equity investments in consumer companies with total revenues in excess of $2.0 billion.

“NXT Capital was an excellent financing partner for this acquisition,” said Corby Reese, a managing director at Swander Pace Capital.

“NXT’s responsiveness and flexibility helped us move quickly to a smooth closing.” added Mark Poff, a managing director at Swander Pace Capital.

Captek Softgel International is a leading FDA-registered and audited, GMP-certified contract manufacturer of custom dietary supplement formulations for the U.S. and international markets. The company is headquartered in Cerritos, California.

NXT Capital provides structured financing solutions through its corporate finance, equipment finance and real estate finance groups. NXT is based in Chicago with offices in Atlanta, Charlotte, Dallas, Los Angeles, Nashville, New York, Phoenix, San Francisco and Stamford.